ELIZABETH BARTON: Open Payments
NPI 1629738844 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,825 in 89 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $661 · 2025 $1,825
Food & beverage: $1,825
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $469 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $173 |
| Amgen Inc. | 10 | $161 |
| Corcept Therapeutics | 6 | $113 |
| Xeris Pharmaceuticals, Inc. | 5 | $111 |
| Lilly USA, LLC | 6 | $104 |
| PFIZER INC. | 5 | $102 |
| Dexcom, Inc. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
Products named: Ozempic, JARDIANCE, Korlym, GVOKE HYPOPEN, OTEZLA, Dexcom G6 Transmitter, Rybelsus, MOUNJARO.
Industry payments across FL — which companies pay providers there.
